LENZ Therapeutics, Inc. (LENZ) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 461.01M |
| Enterprise Value | 436.65M |
| P/E Ratio | -0.68 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 7.75 |
| Price/Book Ratio | 0.44 |
| Enterprise/Revenue | 5.81 |
| Enterprise/EBITDA | -0.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -11.35 |
| Operating Margin | -12.11 |
| Return On Assets | -0.59 |
| Return On Equity | -0.59 |
| Revenue | 19.09M |
| Revenue/Share | 0.39 |
| Gross Profit | 18.38M |
| EBITDA | -81.34M |
| Net Income | -82.13M |
| Diluted EPS | -2.85 |
| Total Cash | 220M |
| Total Cash/Share | 7 |
| Total Debt | 122,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 13.55 |
| Book Value Per Share | 6.98 |
| 52-Week Change | -89.08 |
| 52-Week High | 32.13 |
| 52-Week Low | 2.83 |
| Moving Average 50 Days | 4.07 |
| Moving Average 200 Days | 8.02 |
| Average Volume | 842,910 |
| Shares Outstanding | 31.42M |
| % Held by Institutions | 111.21 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | March 22, 2024 |